CAS: 150450-53-6 - 4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-
Formula:C16H12ClN3O2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro- REF: IN-DA001MMSCAS: 150450-53-6 | 99% | To inquire | Tue 21 Jan 25 |
 | MBCQ REF: TM-T21965CAS: 150450-53-6 | 99.45% | 45.00 €~1,179.00 € | Mon 27 Jan 25 |
 | MBCQ REF: 3D-AGA45053CAS: 150450-53-6 | Min. 95% | - - - | Discontinued product |
4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-
CAS:150450-53-6
Formula:
C16H12ClN3O2
Purity:
99%
Color and Shape:
Solid
Molecular weight:
313.7384
Ref: IN-DA001MMS
| 10mg | 161.00 € | ||
| 25mg | 318.00 € | ||
| 50mg | 479.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
MBCQ
CAS:150450-53-6
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.
Formula:
C16H12ClN3O2
Purity:
99.45%
Color and Shape:
Solid
Molecular weight:
313.74
Ref: TM-T21965
| 5mg | 45.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 141.00 € | ||
| 50mg | 225.00 € | ||
| 100mg | 323.00 € | ||
| 200mg | 451.00 € | ||
| 1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
MBCQ
CAS:150450-53-6
MBCQ is a novel compound that has been shown to be an effective treatment for …
Formula:
C16H12ClN3O2
Purity:
Min. 95%
Molecular weight:
313.74 g/mol
Ref: 3D-AGA45053
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
